 |
 |
 |
|
REVERSIBILITY OF TAF- AND/OR INSTI-ASSOCIATED WEIGHT GAIN
|
|
|
CROI 2023 Feb 20-23
Myrthe L. Verburgh1,2,3, Ferdinand W.N.M. Wit1,2,4, Anders Boyd4,5, Peter Reiss1,2,3,6 and Marc van der Valk1,2,4; for the ATHENA HIV observational cohort study
1 Amsterdam UMC location University of Amsterdam, Infectious Diseases, Amsterdam, The Netherlands; 2 Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands; 3 Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands; 4 HIV Monitoring Foundation, Amsterdam, The Netherlands; 5 Public Health Service of Amsterdam, Infectious Diseases, Amsterdam, The Netherlands; 6 Amsterdam UMC location University of Amsterdam, Global Health, Amsterdam, The Netherlands





|
|
|
 |
 |
|
|